Atossa TherapeuticsATOS
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 77 institutions reported holding Atossa Therapeutics Inc. (ATOS) in their 13F filings, up 10 from Q1 2024. 26 opened new positions and 17 sold out. The largest holders were BlackRock Inc. ($10.9M), Vanguard Group Inc. ($7.7M) and Geode Capital Management, LLC ($3.3M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Atossa Therapeutics Inc.
- CUSIP
- 04962H506
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 26 | $943K |
| Exits | 17 | $6.0M |
All 13F filers, Q1 2024 → Q2 2024: 12,446,786 shares bought and 5,536,928 shares sold, net +6,909,858 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 77 holders
| BlackRock Inc. | 0.00% | Add +234.3% | 9,197,040 | $10.9M |
| Vanguard Group Inc. | 0.00% | Add +12.7% | 6,485,877 | $7.7M |
| Geode Capital Management, LLC | 0.00% | Add +128.5% | 2,769,684 | $3.3M |
| State Street Corp. | 0.00% | Add +236.9% | 1,663,041 | $2.0M |
| Renaissance Technologies | 0.00% | Add +11.9% | 1,550,910 | $1.8M |
| Morgan Stanley | 0.00% | Reduce -40.4% | 456,153 | $543K |
| Bank of New York Mellon Corp | 0.00% | Add +3160.5% | 411,667 | $490K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +705.0% | 369,988 | $440K |
| Northern Trust Corp. | 0.00% | Add +18.4% | 267,208 | $318K |
| Jane Street Group, LLC | 0.00% | Add +566.0% | 260,081 | $309K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +36.6% | 209,241 | $249K |
| Citadel Advisors | 0.00% | Add +59.9% | 201,498 | $240K |
| Two Sigma Investments, LP | 0.00% | Add +450.5% | 182,786 | $218K |
| Nuveen Asset Management, LLC | 0.00% | New | 170,733 | $203K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -36.7% | 157,426 | $187K |
| Rhumbline Advisers | 0.00% | New | 135,118 | $161K |
| Mariner, LLC | 0.00% | No change | 105,910 | $126K |
| Bank of America Corp. | 0.00% | Add +32.2% | 105,672 | $126K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -83.7% | 102,665 | $122K |
| New York State Common Retirement Fund | 0.00% | New | 87,800 | $104K |
| Virtu Financial LLC | 0.01% | Reduce -10.5% | 75,126 | $89K |
| Corebridge Financial, Inc. | 0.00% | — | 68,049 | $82K |
| Squarepoint Ops LLC | 0.00% | Reduce -40.3% | 66,541 | $79K |
| Cetera Investment Advisers | 0.00% | Add +27.4% | 59,543 | $71K |
| Invesco Ltd. | 0.00% | New | 57,901 | $69K |
| Two Sigma Advisers, LP | 0.00% | Add +193.0% | 54,200 | $64K |
| JPMorgan Chase & Co. | 0.00% | Add +57345.7% | 53,999 | $64K |
| Citigroup Inc. | 0.00% | Reduce -70.9% | 53,158 | $63K |
| Wells Fargo & Company | 0.00% | Add +5661.7% | 53,065 | $63K |
| Edmond DE Rothschild Holding S.A. | 0.00% | No change | 50,000 | $60K |
| Voya Investment Management LLC | 0.00% | New | 46,349 | $55K |
| LPL Financial LLC | 0.00% | Reduce -0.5% | 45,517 | $54K |
| Barclays PLC | 0.00% | New | 44,035 | $52K |
| UBS Group AG | 0.00% | Add +9699.3% | 41,451 | $49K |
| MetLife Investment Management, LLC | 0.00% | New | 33,405 | $40K |
| Regions Financial Corp. | 0.00% | No change | 30,000 | $36K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2971600.0% | 29,717 | $35K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -1.1% | 26,023 | $31K |
| XTX Topco Ltd | 0.00% | New | 24,665 | $29K |
| Group One Trading LLC | 0.00% | Reduce -77.3% | 24,198 | $29K |
| PFG Investments, LLC | 0.00% | No change | 23,650 | $28K |
| Wolverine Trading, LLC | 0.00% | Reduce -52.3% | 23,363 | $28K |
| LVM Capital Management Ltd. | 0.00% | No change | 21,000 | $25K |
| BNP Paribas Financial Markets | 0.00% | Add +327.2% | 19,459 | $23K |
| Alliancebernstein L.P. | 0.00% | New | 17,380 | $21K |
| NorthRock Partners, LLC | 0.00% | New | 16,750 | $20K |
| Victory Capital Management Inc. | 0.00% | New | 16,200 | $19K |
| Koss-Olinger Consulting, LLC | 0.00% | New | 15,000 | $18K |
| NewEdge Advisors, LLC | 0.00% | New | 15,000 | $18K |
| Ground Swell Capital, LLC | 0.02% | New | 14,466 | $17K |
| Principal Financial Group Inc. | 0.00% | New | 13,207 | $16K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 12,392 | $15K |
| Alpine Global Management, LLC | 0.00% | New | 12,168 | $14K |
| Legal & General Group Plc | 0.00% | New | 11,829 | $14K |
| SG Americas Securities, LLC | 0.00% | New | 11,812 | $14K |
| Royal Bank of Canada | 0.00% | Add +23227.5% | 11,897 | $14K |
| Janney Montgomery Scott LLC | 0.00% | New | 11,500 | $14K |
| J. L. Bainbridge & Co., Inc. | 0.00% | No change | 11,121 | $13K |
| Osaic Holdings, Inc. | 0.00% | Reduce -5.2% | 10,950 | $13K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | No change | 10,815 | $13K |
| Millennium Management | 0.00% | Reduce -99.0% | 10,662 | $13K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 10,600 | $13K |
| Evanson Asset Management, LLC | 0.00% | New | 10,000 | $12K |
| California State Teachers Retirement System | 0.00% | New | 9,165 | $11K |
| Amalgamated Bank | 0.00% | New | 4,376 | $5K |
| FMR LLC | 0.00% | Reduce -1.3% | 4,109 | $5K |
| Silicon Valley Capital Partners | 0.00% | No change | 3,875 | $5K |
| Harbour Investments, Inc. | 0.00% | No change | 1,711 | $2K |
| St. Johns Investment Management Company, LLC | 0.00% | No change | 1,550 | $2K |
| Planning Capital Management Corp | 0.00% | New | 1,000 | $1K |
| Allworth Financial LP | 0.00% | No change | 702 | $941 |
| TD Waterhouse Canada Inc. | 0.00% | Reduce -7.1% | 650 | $774 |
| Unique Wealth Strategies, LLC | 0.00% | New | 166 | $299 |
| Delos Wealth Advisors, LLC | 0.00% | No change | 100 | $119 |
| Clearstead Advisors, LLC | 0.00% | No change | 70 | $84 |
| T. Rowe Price Associates Inc. | 0.00% | New | 40,770 | $0 |
| Hantz Financial Services, Inc. | 0.00% | No change | 82 | $0 |
"% of holder's portfolio" is ATOS's weight in each manager's 13F, not the share of Atossa Therapeutics Inc. the manager owns.